Metformin - its anti-cancer effects in hematologic malignancies
The main anti-diabetic effect of metformin mediated through stimulation of adenosine monophosphate (AMP)-activated protein kinase (AMPK) is the inhibition of hepatic gluconeogenesis and triggering glucose uptake in skeletal muscles. Additionally, some new pathways, besides the AMPK activation, were...
Saved in:
Main Author: | Monika Podhorecka (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biological relevance of alternative splicing in hematologic malignancies
by: Monika Szelest, et al.
Published: (2024) -
Deubiquitinases in hematological malignancies
by: Hu Lei, et al.
Published: (2021) -
Advances in Hematologic Malignancies
Published: (2019) -
Secondary hematological malignancies following breast cancer treatment
by: Soley Bayraktar, et al.
Published: (2011) -
The casein kinase 2 inhibitor, CX-4945, as an anti-cancer drug in treatment of human hematological malignancies
by: Hae Jung eChon, et al.
Published: (2015)